Related Experiment Video
Updated: Aug 18, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[Treatment strategy in childhood bronchial asthma]
R Schuster1, V Sollich, W Thal
1Klinik für Kinderheilkunde, Medizinischen Akademie Magdeburg.
Insights
Early diagnosis and systematic treatment are crucial for managing childhood bronchial asthma. Prompt intervention improves long-term outcomes for pediatric asthma patients.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
Context:
- Bronchial asthma is a prevalent chronic childhood illness.
- Delayed diagnosis hinders timely and effective treatment.
- Understanding asthma's inflammatory basis is key.
Purpose:
- To emphasize the importance of early diagnosis and accurate disease pattern estimation in pediatric asthma.
- To highlight the shift towards prophylactic anti-inflammatory treatment based on new pathogenetic insights.
- To outline current asthma management strategies, including bronchodilatory medication and inhalative routes.
Summary:
- Effective management of childhood bronchial asthma requires early identification and a systematic approach to treatment.
- Current treatment emphasizes prophylactic anti-inflammatory therapies, with bronchodilators used for severe cases.
- Inhalative medication delivery is suitable for all pediatric age groups, supported by ongoing medical supervision.
Impact:
- Improved long-term prognosis for children with bronchial asthma through timely and appropriate care.
- Systematic treatment can lead to symptom resolution in a majority of pediatric asthma cases.
- Integration of new pathogenetic knowledge into clinical practice enhances asthma management strategies.
Abstract:
Although bronchial asthma is the most frequent chronic disease in childhood, not all of the affected children are readily recognised as asthmatics well in time for appropriate treatment. Since most of the children can get rid of the symptoms if all the available treatment methods are made use of systematically, early diagnosis and correct estimation of the disease pattern are essential for good long-term prognosis. New pathogenetic knowledge on the importance of inflammatory processes affecting the bronchial mucosa has definitely shifted the points of emphasis in asthma treatment as is evident from the international consensus recommendations. Focus of drug therapy is on prophylactic antiphlogistic treatment. Only in cases of severe asthma continual bronchodilatory medication is also recommended. The inhalative route is beneficial and feasible for all age groups. Long-term treatment, wherever necessary, also includes continual medical supervision in consultation with a paediatric pneumologist.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...